Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple vs Dual Lipid-Lowering Therapy in Acute Coronary Syndrome
NCT07508254Phase 4Not yet recruiting
- Sponsor
- Punjab Institute of Cardiology
- Start
- May 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bempedoic acid in acute coronary syndrome (ACS), hypercholesterolemia, sponsored by Punjab Institute of Cardiology. Planned start May 2026; status: not yet recruiting.
02
Drugs
bempedoic acid
03
Conditions
acute coronary syndrome (ACS)hypercholesterolemia
Beyond the preview
Go deeper on NCT07508254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07508254.